UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR Section 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~February~~August 148, 2025

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Cayman Islands		001-42451		N/A
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)

52 E. 83rd Street,

New York, New York

10028

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code (917) 979-3072

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant	TDACU	The Nasdaq Stock Market LLC
Class A ordinary shares, $0.0001 par value per share	TDAC	The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	TDACW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information relating to the Note included in Item 8.01 is incorporated by reference in this item to the extent required herein.

Item 8.01. Other Events.

~~As previously~~On ~~reported~~August ~~on December 25~~8, ~~2024~~2025, TDAC Partners LLC (“Sponsor”) agreed to loan to Translational Development Acquisition Corp. (the “Company”) up ~~consummated~~to ~~its~~an ~~initial public~~aggregate ~~offering~~ of 17$2,~~250~~000,000 ~~units~~for working capital purposes. The loan is evidenced by a promissory note (the “~~Units~~Note”), which ~~included~~is ~~2,250,000~~non-interest ~~Units~~bearing ~~issued~~and ~~pursuant~~repayable toon the ~~exercise~~earlier ~~in full~~ of (i) the ~~underwriters’~~date ~~over-allotment~~by ~~option.~~which ~~Each~~the ~~Unit~~Company ~~consists~~has ofto ~~one~~complete ~~Class~~a Amerger, ~~ordinary~~ share ~~(“Ordinary Share”)~~exchange, ~~and~~asset ~~one~~acquisition, ~~warrant~~share ~~(“Warrant”).~~purchase, ~~Each~~reorganization ~~Warrant~~or ~~entitles~~other ~~its~~similar ~~holder~~business tocombination ~~purchase~~with one ~~Ordinary~~or ~~Share~~more atbusinesses aor ~~price~~entities ofto ~~$11.50 per~~the ~~share~~Company’s Amended and Restated Memorandum of Association (~~subject~~as toit ~~adjustment).~~may ~~The~~be ~~Units~~amended ~~were~~from ~~sold~~time atto time) (a ~~price~~“Business ofCombination”), and ~~$10.00~~(ii) ~~per~~the ~~Unit,~~effective ~~generating~~date ~~gross~~of ~~proceeds~~a toBusiness ~~the~~Combination ~~Company~~(such earlier date of ~~$172~~(i) and (ii),~~500,000~~ the “Maturity Date”).

~~On February~~If ~~14, 2025,~~ the Company ~~issued~~does not consummate a ~~press~~Business ~~release~~Combination, athe ~~copy~~Note ofwill ~~which~~not isbe ~~attached~~repaid asand ~~Exhibit~~all ~~99.1~~amounts owed under the Note will be forgiven except to ~~this~~the ~~Current~~extent ~~Report~~that onthe ~~Form~~Company ~~8-K,~~has ~~announcing~~funds available to it outside of its trust account established in connection with the initial ~~that~~public ~~separate~~offering ~~trading~~(the “Trust Account”). The issuance of ~~Ordinary~~the ~~Shares~~Note ~~and~~was ~~Warrants~~exempt ~~comprising~~pursuant to Section 4(a)(2) of the ~~Units~~Securities Act ~~has~~of ~~commenced~~1933, as amended.

The foregoing summary of the Note is qualified in its entirety by reference to the text of the Note, which is filed as an exhibit hereto and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibits.
	The following exhibits are being filed herewith:
99.1	Press Release dated February 14, 2025
10.1	Promissory Note, dated August 8, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: ~~February~~August 14, 2025

TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

By:	/s/ Michael B. Hoffman
Name:	Michael B. Hoffman
Title:	Chief Executive Officer

Filing Compare · Translational Development Acquisition Corp.